Innovative Biotech Nig. Ltd. WHO: What is Africa’s vaccine production capacity? Accra, 18 March 2021 – COVID-19 vaccination in Africa is gathering pace, with more than 7 million doses so far administered.
But the continent received vaccines later than other regions of the world and in limited quantity. A few weeks after launching vaccinations, some countries are nearly exhausting their initial supplies. Egypt (Sinovac) Biovac (South Africa; ImmunityBio) Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter The BioVac Institute, a state-backed South African vaccine company, plans to use a deal it won to manufacture coronavirus shots as a stepping stone toward developing an inoculation export industry in the country.
The contract with U.S. -based ImmunityBio Inc., which is conducting phase 1 vaccine trials in South Africa and the U.S., will allow BioVac to transform itself from a facility that merely packages and labels the shots to one that makes the raw materials, Morena Makhoana, BioVac’s chief executive officer, said in an interview on Friday. Aspen Pharmacare (South Africa; J&J)